Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-08-01

FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)

View source ↗

Summary

FDA approved a Supplemental Application for Extraneal, an icodextrin-containing peritoneal dialysis solution, submitted by Vantive US Healthcare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extraneal (icodextrin)

Snippet

SUPPL AP for EXTRANEAL (ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)